Option Care Health, Inc. (NASDAQ:OPCH) Shares Acquired by AlphaQuest LLC

AlphaQuest LLC boosted its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 417.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 23,520 shares of the company’s stock after purchasing an additional 18,978 shares during the period. AlphaQuest LLC’s holdings in Option Care Health were worth $546,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the company. Wellington Management Group LLP grew its holdings in Option Care Health by 15.5% during the 3rd quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company’s stock valued at $310,650,000 after purchasing an additional 1,328,326 shares in the last quarter. FMR LLC grew its holdings in Option Care Health by 134.0% during the 3rd quarter. FMR LLC now owns 7,516,448 shares of the company’s stock worth $235,265,000 after acquiring an additional 4,304,896 shares in the last quarter. Westfield Capital Management Co. LP grew its holdings in Option Care Health by 10.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock worth $203,204,000 after acquiring an additional 599,589 shares in the last quarter. State Street Corp grew its holdings in Option Care Health by 1.4% during the 3rd quarter. State Street Corp now owns 6,257,172 shares of the company’s stock worth $195,849,000 after acquiring an additional 83,395 shares in the last quarter. Finally, Thrivent Financial for Lutherans grew its holdings in Option Care Health by 7.4% during the 3rd quarter. Thrivent Financial for Lutherans now owns 5,863,930 shares of the company’s stock worth $183,541,000 after acquiring an additional 404,811 shares in the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on OPCH shares. Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and raised their price objective for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $26.00 to $33.00 in a report on Monday, January 13th. JMP Securities reissued a “market outperform” rating and set a $30.00 price objective (down from $31.00) on shares of Option Care Health in a report on Friday, January 10th. JPMorgan Chase & Co. raised their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a report on Thursday, March 6th. Finally, Barrington Research lifted their price target on shares of Option Care Health from $33.00 to $38.00 and gave the company an “outperform” rating in a report on Thursday, February 27th. Two analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $33.00.

Insider Activity at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares in the company, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.64% of the stock is currently owned by insiders.

Option Care Health Trading Down 1.6 %

NASDAQ OPCH opened at $32.89 on Thursday. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $34.85. The company has a 50-day simple moving average of $30.44 and a 200-day simple moving average of $28.22. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The firm has a market capitalization of $5.44 billion, a PE ratio of 27.64, a price-to-earnings-growth ratio of 2.30 and a beta of 1.33.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.